REPORT ID 509

United States Self-administered Drugs Market Report 2017

Publish Date
04-Dec-17
Pages
98
Format
Electronic (PDF)

In this report, the United States Self-administered Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Self-administered Drugs in these regions, from 2012 to 2022 (forecast).

United States Self-administered Drugs market competition by top manufacturers/players, with Self-administered Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abbott Laboratories
    Bristol-Myers Squibb
    Novartis AG
    Eli Lilly and Company
    Gilead Sciences
    Antares Pharma
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Injectable Drugs
    Inhaled Drugs
    Transdermal Drugs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Cardiovascular Diseases
    Diabetes
    Osteoporosis
    Pain Management
    Hormone Replacement
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Self-administered Drugs Market Report 2017
1 Self-administered Drugs Overview
    1.1 Product Overview and Scope of Self-administered Drugs
    1.2 Classification of Self-administered Drugs by Product Category
        1.2.1 United States Self-administered Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Self-administered Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Injectable Drugs
        1.2.4 Inhaled Drugs
        1.2.5 Transdermal Drugs
    1.3 United States Self-administered Drugs Market by Application/End Users
        1.3.1 United States Self-administered Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Cardiovascular Diseases
        1.3.3 Diabetes
        1.3.4 Osteoporosis
        1.3.5 Pain Management
        1.3.6 Hormone Replacement
        1.3.7 Others
    1.4 United States Self-administered Drugs Market by Region
        1.4.1 United States Self-administered Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Self-administered Drugs Status and Prospect (2012-2022)
        1.4.3 Southwest Self-administered Drugs Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Self-administered Drugs Status and Prospect (2012-2022)
        1.4.5 New England Self-administered Drugs Status and Prospect (2012-2022)
        1.4.6 The South Self-administered Drugs Status and Prospect (2012-2022)
        1.4.7 The Midwest Self-administered Drugs Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Self-administered Drugs (2012-2022)
        1.5.1 United States Self-administered Drugs Sales and Growth Rate (2012-2022)
        1.5.2 United States Self-administered Drugs Revenue and Growth Rate (2012-2022)

2 United States Self-administered Drugs Market Competition by Players/Suppliers
    2.1 United States Self-administered Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Self-administered Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Self-administered Drugs Average Price by Players/Suppliers (2012-2017)
    2.4 United States Self-administered Drugs Market Competitive Situation and Trends
        2.4.1 United States Self-administered Drugs Market Concentration Rate
        2.4.2 United States Self-administered Drugs Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Self-administered Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Self-administered Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Self-administered Drugs Sales and Market Share by Region (2012-2017)
    3.2 United States Self-administered Drugs Revenue and Market Share by Region (2012-2017)
    3.3 United States Self-administered Drugs Price by Region (2012-2017)

4 United States Self-administered Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Self-administered Drugs Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Self-administered Drugs Revenue and Market Share by Type (2012-2017)
    4.3 United States Self-administered Drugs Price by Type (2012-2017)
    4.4 United States Self-administered Drugs Sales Growth Rate by Type (2012-2017)

5 United States Self-administered Drugs Sales (Volume) by Application (2012-2017)
    5.1 United States Self-administered Drugs Sales and Market Share by Application (2012-2017)
    5.2 United States Self-administered Drugs Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Self-administered Drugs Players/Suppliers Profiles and Sales Data
    6.1 Abbott Laboratories
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Self-administered Drugs Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Abbott Laboratories Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Bristol-Myers Squibb
        6.2.2 Self-administered Drugs Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Bristol-Myers Squibb Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Novartis AG
        6.3.2 Self-administered Drugs Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Novartis AG Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Eli Lilly and Company
        6.4.2 Self-administered Drugs Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Eli Lilly and Company Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Gilead Sciences
        6.5.2 Self-administered Drugs Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Gilead Sciences Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Antares Pharma
        6.6.2 Self-administered Drugs Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Antares Pharma Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    ...

7 Self-administered Drugs Manufacturing Cost Analysis
    7.1 Self-administered Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Self-administered Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Self-administered Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Self-administered Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Self-administered Drugs Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Self-administered Drugs Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Self-administered Drugs Sales Volume Forecast by Type (2017-2022)
    11.3 United States Self-administered Drugs Sales Volume Forecast by Application (2017-2022)
    11.4 United States Self-administered Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer